Outcomes with novel combinations in nonclear cell renal cell carcinoma (nccRCC): ORACLE study.

Overview of attention for article published in Journal of Clinical Oncology, June 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 1 X user

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 1 X post from an account with 16,108 followers.

Data is limited regarding the role of novel agents in non-clear cell renal cell carcinoma (nccRCC); our work in the ORACLE study showed that novel agents have a role in such a setting. https://t.co/NfhuGCLWKq

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.